Fertility-preserving treatment in young patients with endometrial adenocarcinoma

Cancer

Volumn 94, Issue 8, 2002, Pages 2192-2198

  Wang, Chen Bin ^a   Wang, Chin Jung ^a   Huang, Huei Jean ^a   Hsueh, Swei ^a   Chou, Hung Hsueh ^a   Soong, Yung Kuei ^a   Lai, Chyong Huey ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Endometrial carcinoma; Gonadotropin releasing hormone analog; Hysteroscopy; Megestrol acetate; Tamoxifen

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; GONADORELIN DERIVATIVE; MEGESTROL ACETATE; PROGESTERONE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; ARTICLE; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CLINICAL ARTICLE; COHORT ANALYSIS; DRUG EFFICACY; ENDOMETRIUM CARCINOMA; FEMALE; FEMALE FERTILITY; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; OUTCOMES RESEARCH; PREGNANCY; PRIORITY JOURNAL; RECEPTOR AFFINITY; TREATMENT FAILURE;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; FEMALE; FERTILITY; GONADOTROPIN-RELEASING HORMONE; HUMANS; MEGESTROL; MEGESTROL ACETATE; PELVIS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TAMOXIFEN; TREATMENT OUTCOME;

EID: 0037089666     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10435     Document Type: Article

References (30)

1. Endometrial carcinoma in women 40 years of age or younger
2. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women
3. Endometrial adenocarcinoma in Stein-Leventhal syndrome
4. Primary treatment of endometrial cancer with progestagen alone
5. Can primary endometrial carcinoma Stage I be cured without surgery and radiation therapy?
6. Endometrial adenocarcinoma in women under 25 years of age
7. Complex endometrial hyperplasia and carcinoma in adolescents and young women 15 to 20 years of age: A report of 10 cases
8. Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy
9. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40
10. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma
11. DNA aneuploidy of normal tissues and benign tumors of the female genital tract
12. Endometrial cancer: Histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor
13. Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma
14. Systemic treatment of advanced and recurrent endometrial carcinoma: Current status and future directions
15. Tamoxifen therapy in advanced/recurrent endometrial carcinoma
16. Apparent resistance in human endometrial carcinoma during combination treatment with tamoxifen and progestin may result from desensitization following downregulation of tumor progesterone receptor
17. Megestrol and tamoxifen in patients with advanced endometrial cancer: An Eastern Cooperative Oncology Group study
18. The predictive value of progesterone receptor levels in endometrial cancer
19. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium
20. Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate?
21. Radiologic staging in patients with endometrial cancer: A meta-analysis
22. A new treatment for endometrial cancer with gonadotrophin releasing-hormone analogue
23. Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer
24. Detection and partial characterization of receptors for [D- Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma
25. Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis
26. Endometrial carcinoma in a young patient with polycystic ovarian syndrome: First suspected at time of embryo transfer
27. Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma
28. Value of peritoneal cytology after hysteroscopy in surgical stage I adenocarcinoma of the endometrium
29. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease
30. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate